AU3579200A - Method and composition for the regulation of hepatic and extrahepatic productionof insulin-like growth factor-1 - Google Patents

Method and composition for the regulation of hepatic and extrahepatic productionof insulin-like growth factor-1

Info

Publication number
AU3579200A
AU3579200A AU35792/00A AU3579200A AU3579200A AU 3579200 A AU3579200 A AU 3579200A AU 35792/00 A AU35792/00 A AU 35792/00A AU 3579200 A AU3579200 A AU 3579200A AU 3579200 A AU3579200 A AU 3579200A
Authority
AU
Australia
Prior art keywords
productionof
extrahepatic
hepatic
insulin
regulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35792/00A
Inventor
Olle Isaksson
John-Olov Jansson
Claes Olsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SALTECH I GOTEBORG AB
Original Assignee
SALTECH I GOTEBORG AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9900708A external-priority patent/SE9900708L/en
Priority claimed from SE9903108A external-priority patent/SE9903108D0/en
Application filed by SALTECH I GOTEBORG AB filed Critical SALTECH I GOTEBORG AB
Publication of AU3579200A publication Critical patent/AU3579200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AU35792/00A 1999-02-26 2000-02-28 Method and composition for the regulation of hepatic and extrahepatic productionof insulin-like growth factor-1 Abandoned AU3579200A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9900708 1999-02-26
SE9900708A SE9900708L (en) 1999-02-26 1999-02-26 Method and composition for controlling hepatic and extrahepatic production of insulin-like growth factor-1
SE9903108A SE9903108D0 (en) 1999-09-01 1999-09-01 Effect of systemic liver derived IGF-1 on the treatment of obesity
SE9903108 1999-09-01
PCT/SE2000/000391 WO2000050067A1 (en) 1999-02-26 2000-02-28 Method and composition for the regulation of hepatic and extrahepatic production of insulin-like growth factor-1

Publications (1)

Publication Number Publication Date
AU3579200A true AU3579200A (en) 2000-09-14

Family

ID=26663518

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35792/00A Abandoned AU3579200A (en) 1999-02-26 2000-02-28 Method and composition for the regulation of hepatic and extrahepatic productionof insulin-like growth factor-1

Country Status (2)

Country Link
AU (1) AU3579200A (en)
WO (1) WO2000050067A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2433800C (en) 2001-01-05 2016-09-13 Pfizer Inc. Antibodies to insulin-like growth factor i receptor
CA2484000A1 (en) 2002-05-24 2003-12-04 Schering Corporation Neutralizing human anti-igfr antibody
US20040121407A1 (en) * 2002-09-06 2004-06-24 Elixir Pharmaceuticals, Inc. Regulation of the growth hormone/IGF-1 axis
ATE514783T1 (en) 2003-11-12 2011-07-15 Schering Corp PLASMID SYSTEM FOR EXPRESSING MULTIPLE GENES
AR046639A1 (en) 2003-11-21 2005-12-14 Schering Corp ANTI-IGFR1 ANTIBODY THERAPEUTIC COMBINATIONS
EP2283831A3 (en) 2004-12-03 2013-10-23 Merck Sharp & Dohme Corp. Biomakers for pre-selection of patients for anti-IGF1R therapy
WO2010146059A2 (en) 2009-06-16 2010-12-23 F. Hoffmann-La Roche Ag Biomarkers for igf-1r inhibitor therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07508025A (en) * 1992-05-08 1995-09-07 トーマス・ジェファーソン・ユニバーシティ Insulin-like growth factor (IGF-1) analogs
EP0708655A1 (en) * 1993-04-07 1996-05-01 Amgen Boulder Inc. Methods of using insulin-like growth factor binding proteins
US5504074A (en) * 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
EP0871475A2 (en) * 1995-09-14 1998-10-21 Bristol-Myers Squibb Company Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors
PT771817E (en) * 1995-10-30 2003-06-30 Oleoyl Estrone Developments S OLEATE ESTERS OF ESTROGEN FOR THE TREATMENT OF OBESITY AND / OR EXCESS OF WEIGHT

Also Published As

Publication number Publication date
WO2000050067A1 (en) 2000-08-31

Similar Documents

Publication Publication Date Title
AU3933200A (en) Compositions and methods for controlling pests
AU6283299A (en) Controlled release nanoparticulate compositions
AU7490200A (en) New and improved formulation for paclitaxel
AU2695795A (en) Piperazine compounds promote release of growth hormone
EP1175213A4 (en) Heterocyclic aromatic compounds useful as growth hormone secretagogues
HUP0203746A3 (en) Novel composition and method for stabilizing the same
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
EG22592A (en) Coated fertilizer composition and method for its production
AU7906998A (en) Compounds with growth hormone releasing properties
HK1046530A1 (en) Heterocyclic ketone and thioester compounds and uses
AU6056500A (en) Process and composition for temporarily suppressing pain
AU3579200A (en) Method and composition for the regulation of hepatic and extrahepatic productionof insulin-like growth factor-1
AU3142400A (en) A pharmaceutical composition for treating angiocardiopathy and the method of producing thereof
AUPQ579800A0 (en) Plant growth hormone compositions
AU7056000A (en) Powder coating composition
AU5671099A (en) Compounds having growth hormone releasing activity
AU7715300A (en) Method of preventing osteoporosis
AU3576300A (en) Method and composition for controlling lice
AU5804399A (en) Antimicrobial composition for handwash and a method of cleaning skin using the same
AU2842501A (en) Method of controlling weeds
AU3844500A (en) Composition of rigid growing substrate and method of producing same
AU7686800A (en) Plant disease controlling compositions and plant disease controlling method
AU3052500A (en) Ceramic paste composition and prototyping method
AU7901000A (en) Method for modifying coating materials
AU1302899A (en) Antisense compounds to insulin-like growth factor-1 receptor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase